Marc E Buyse

48.5k citations
435 papers · 37.8k · 11 hit papers · h-index 90

Impact in

  • Oncology top 0.05%
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Surgical Treatments
    • HER2/EGFR in Cancer Research
    • Breast Cancer Treatment Studies

Papers in

    • Statistical Methods in Clinical Trials 182
    • Colorectal Cancer Treatments and Studies 66
    • Colorectal Cancer Surgical Treatments 34
    • HER2/EGFR in Cancer Research 27

Marc E Buyse

419 papers receiving 36.2k citations

Marc E Buyse's Hit Papers

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer 2017 · 346 citations
3460+10+20Years since publication5001k1.5k2k

Peers

Marc E Buyse
Comparison fields: 5 of 184
  • Oncology 13.4k
  • Cancer Research 6.9k
  • Statistics and Probability 4.7k
  • Pulmonary and Respiratory Medicine 4.9k
  • Reproductive Medicine 1.6k
Replace Richard Pazdur with:
Richard Pazdur United States
Larry Rubinstein United States
Richard L. Schilsky United States
Daniel J. Sargent United States
Richard S. Kaplan United Kingdom
Richard D. Gelber United States
Robert J. Gray United States
Janet Ellen Dancey United States
Mahesh Parmar United Kingdom
Denis Lacombe Belgium
Marc E Buyse relative to Richard Pazdur United States Richard Pazdur's profile →
Citations per field
00.5×2×2.8×
Richard Pazdur · 1×
Citations per year

Countries citing papers authored by Marc E Buyse

Since Specialization
Citations

This map shows the geographic impact of Marc E Buyse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc E Buyse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc E Buyse more than expected).

Fields of papers citing papers by Marc E Buyse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc E Buyse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc E Buyse. The network helps show where Marc E Buyse may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc E Buyse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc E Buyse Line = papers co-authored together Marc E Buyse links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 435 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
Hit paper breakdown →
20032466
2
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Hit paper breakdown →
20112168
3
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
Hit paper breakdown →
20061646
4
Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases
Hit paper breakdown →
19971271
5
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
Hit paper breakdown →
2006953
6
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.
Hit paper breakdown →
1998840
7 2007774
8 2008683
9 2007660
10 2006653
11 2009649
12 2005596
13 1988559
14
The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer
Hit paper breakdown →
1995548
15 2009536
16
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
Hit paper breakdown →
2015514
17
The Effect of Debulking Surgery After Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer
Hit paper breakdown →
1995495
18 2000491
19 2017469
20 2016461

About Marc E Buyse

Marc E Buyse is a scholar working on Statistics and Probability, Oncology, Cancer Research, Statistics, Probability and Uncertainty and Pulmonary and Respiratory Medicine, having authored 435 papers that have together received 37.8k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (182 papers), Colorectal Cancer Treatments and Studies (66 papers), Breast Cancer Treatment Studies (51 papers), Colorectal Cancer Surgical Treatments (34 papers), HER2/EGFR in Cancer Research (27 papers), Meta-analysis and systematic reviews (22 papers), Gastric Cancer Management and Outcomes (17 papers) and Ovarian cancer diagnosis and treatment (14 papers). The work is most often cited by research in Oncology (13.4k citations), Cancer Research (6.9k citations), Statistics and Probability (4.7k citations), Pulmonary and Respiratory Medicine (4.9k citations) and Reproductive Medicine (1.6k citations). Marc E Buyse has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Tomasz Burzykowski, Geert Molenberghs, Pascal Piedbois, Aimery de Gramont, Martine J Piccart, Thierry André, Christos P. Sotiriou, Everardo Delforge Saad, Mauro Delorenzi and Christine Desmedt. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Statistics in Medicine, The Lancet Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact